Lyfegen and EVERSANA Collaborate to Revolutionize Drug Pricing and Access with AI-Driven Insights

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Lyfegan-Eversana

More Like This

PR Newswire associated0

Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally

PR Newswire associated0

EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office

PR Newswire associated0

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

PR Newswire associated0

EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate

Sofinnova.AI (Photo: Sofinnova)

Sofinnova Partners Unveils Sofinnova.AI: A Cutting-edge Artificial Intelligence Platform Set to Transform Its Life Sciences Investment Practice

PR Newswire associated0

Boehringer Ingelheim Partners with Veeva to Launch 'One Medicine Platform'

PR Newswire associated0

Boehringer Ingelheim and Cognizant announce the launch of a unified cloud platform to bring innovative therapies to patients faster

Business Wire logo

Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology